Report Library
All ReportsDatamonitor Healthcare CV&Met: Chemotherapy-Induced Anemia Disease Coverage
May 02, 2018
Anemia is a common complication in cancer patients, and can arise due to the malignancy itself (cancer-related anemia) or chemotherapy
treatment (chemotherapy-induced anemia [CIA]). CIA occurs because of the myelotoxicity of chemotherapy drugs, which impairs
erythropoiesis and results in a decreased number of circulating red blood cells and a diminished ability to transport oxygen around the body.
Additionally, there is evidence that anemia lowers patient response to chemotherapy and radiotherapy, as tumor hypoxia can cause resistance to cancer treatment.
This Datamonitor Healthcare Disease Coverage report contains an Epidemiology module.
Additionally, there is evidence that anemia lowers patient response to chemotherapy and radiotherapy, as tumor hypoxia can cause resistance to cancer treatment.
This Datamonitor Healthcare Disease Coverage report contains an Epidemiology module.
Disease Group Covered: | Hematology |